Diana J M van den Wollenberg
11PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 09, 2024
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen
|Mar 02, 2023
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman
|Feb 28, 2023
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells.Selas T F Bots, Sanne L Landman, Martijn J W E Rabelink
|Feb 11, 2023
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines.Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink
|Jul 19, 2022
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans
|Dec 04, 2021
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.Selas T F Bots, Vera Kemp, Steve J Cramer
Pageof 2
Frequent Collaborators
9 joint publications
Rob C Hoeben
5 joint publications
Thorbald van Hall
5 joint publications
Nadine van Montfoort
4 joint publications
Christianne Groeneveldt
4 joint publications
Sjoerd H van der Burg
2 joint publications
Vera Kemp
2 joint publications
Priscilla Kinderman
2 joint publications
Lisa Griffioen
2 joint publications
Martijn J W E Rabelink
2 joint publications
Selas T F Bots
